ADMA BIOLOGICS, INC. Total Assets
ADMA BIOLOGICS, INC. (ADMA) had Total Assets of $684.21 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets
us-gaap:Assets · last filed 2026-08-05
- 2026-06-30: Assets $684.21M.
- 2026-03-31: Assets $665.18M.
- 2025-12-31: Assets $624.24M.
- 2025-09-30: Assets $568.69M.
| Period end | Assets | Assets as first filed |
|---|---|---|
| 2026-06-30 | $684.21M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $665.18M 10-Q · filed 2026-05-06 | |
| 2025-12-31 | $624.24M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $568.69M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $558.38M 10-Q · filed 2026-08-05 | |
| 2025-03-31 | $510.57M 10-Q · filed 2026-05-06 | |
| 2024-12-31 | $488.68M 10-K · filed 2026-02-25 | |
| 2024-09-30 | $390.62M 10-Q · filed 2025-11-05 | |
| 2024-06-30 | $376.40M 10-Q · filed 2025-08-06 | |
| 2024-03-31 | $350.88M 10-Q · filed 2025-05-07 | |
| 2023-12-31 | $329.18M 10-K · filed 2026-02-25 | |
| 2023-09-30 | $349.00M 10-Q · filed 2024-11-07 | $349.00M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $343.03M 10-Q · filed 2024-08-08 | $343.03M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $340.79M 10-Q · filed 2024-05-09 | $340.79M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $348.46M 10-K · filed 2025-03-18 | $348.46M 10-K · filed 2023-03-23 |
| 2022-09-30 | $300.56M 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $296.93M 10-Q · filed 2023-08-09 | |
| 2022-03-31 | $308.03M 10-Q · filed 2023-05-10 | |
| 2021-12-31 | $276.25M 10-K · filed 2024-02-28 | $276.25M 10-K · filed 2022-03-24 |
| 2021-09-30 | $238.64M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $232.81M 10-Q · filed 2022-08-10 | |
| 2021-03-31 | $235.67M 10-Q · filed 2022-05-11 | |
| 2020-12-31 | $207.67M 10-K · filed 2022-03-24 | |
| 2020-09-30 | $189.98M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $191.54M 10-Q · filed 2021-08-11 | |
| 2020-03-31 | $210.52M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $127.09M 10-K · filed 2021-03-25 | |
| 2019-09-30 | $137.78M 10-Q · filed 2019-11-06 | |
| 2019-06-30 | $143.27M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $78.12M 10-Q · filed 2020-05-06 | |
| 2018-12-31 | $88.88M 10-K · filed 2020-03-13 | |
| 2018-09-30 | $106.35M 10-Q · filed 2019-11-06 | |
| 2018-06-30 | $117.75M 10-Q · filed 2019-08-08 | |
| 2018-03-31 | $91.14M 10-Q · filed 2019-05-08 | |
| 2017-12-31 | $108.02M 10-K · filed 2019-03-13 | |
| 2017-09-30 | $72.81M 10-Q · filed 2017-11-03 | |
| 2017-06-30 | $84.64M 10-Q · filed 2017-08-11 | |
| 2017-03-31 | $17.59M 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $23.69M 10-K · filed 2018-03-29 | |
| 2016-09-30 | $27.50M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $31.74M 10-Q · filed 2016-08-12 | |
| 2016-03-31 | $19.68M 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $23.71M 10-K · filed 2017-02-24 | |
| 2015-09-30 | $27.82M 10-Q · filed 2015-11-10 | |
| 2015-06-30 | $29.80M 10-Q · filed 2015-08-11 | |
| 2015-03-31 | $33.93M 10-Q · filed 2015-05-12 | |
| 2014-12-31 | $27.02M 10-K · filed 2016-03-23 | $27.23M 10-K · filed 2015-03-09 |
| 2014-09-30 | $25.29M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $27.88M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $31.95M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $31.98M 10-K · filed 2015-03-09 | |
| 2013-09-30 | $8.70M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $10.69M 10-Q · filed 2013-08-12 | |
| 2013-03-31 | $13.82M 10-Q · filed 2013-05-14 | |
| 2012-12-31 | $15.56M 10-K · filed 2014-03-28 | |
| 2012-09-30 | $13.22M 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $15.88M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $17.01M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $2.93M 10-K · filed 2013-03-06 | $8.08K 10-Q · filed 2012-02-01 |
| 2011-09-30 | $5.91K 10-Q · filed 2011-10-28 | |
| 2011-06-30 | $8.51K 10-Q · filed 2012-02-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |